Completed OBSERVATIONAL NCT00167375

Testing the Nocturnal Sleep Latency Profile in Primary Insomnia

Sponsor: American Academy of Sleep Medicine

Conditions Primary Insomnia Sleep Initiation and Maintenance Disorders

Interventions General cognitive/behavioral interventions for insomnia eszopiclone 3 mg qHS

Updated 7 times since 2017 Last updated: Feb 13, 2008 Started: Jan 31, 2005 Completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00167375, this observational or N/A phase trial focuses on Primary Insomnia and Sleep Initiation and Maintenance Disorders and remains completed. Sponsored by American Academy of Sleep Medicine, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2023 — Jul 2024 [monthly]

Completed
Jan 2021 — Sep 2023 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE1 → None
Jan 2017 — Apr 2018 [monthly]

Completed PHASE1

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Academy of Sleep Medicine
Sumitomo Pharma America, Inc.
University of Pittsburgh

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States